BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12136247)

  • 1. Expression profile of EFNB1, EFNB2, two ligands of EPHB2 in human gastric cancer.
    Kataoka H; Tanaka M; Kanamori M; Yoshii S; Ihara M; Wang YJ; Song JP; Li ZY; Arai H; Otsuki Y; Kobayashi T; Konno H; Hanai H; Sugimura H
    J Cancer Res Clin Oncol; 2002 Jul; 128(7):343-8. PubMed ID: 12136247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexpression of transcripts encoding EPHB receptor protein tyrosine kinases and their ephrin-B ligands in human small cell lung carcinoma.
    Tang XX; Brodeur GM; Campling BG; Ikegaki N
    Clin Cancer Res; 1999 Feb; 5(2):455-60. PubMed ID: 10037197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of EphB2-tyrosine kinase receptor and its ligand conveys dorsalization signal in Xenopus laevis development.
    Tanaka M; Wang DY; Kamo T; Igarashi H; Wang Y; Xiang YY; Tanioka F; Naito Y; Sugimura H
    Oncogene; 1998 Sep; 17(12):1509-16. PubMed ID: 9794228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas.
    Tang XX; Evans AE; Zhao H; Cnaan A; London W; Cohn SL; Brodeur GM; Ikegaki N
    Clin Cancer Res; 1999 Jun; 5(6):1491-6. PubMed ID: 10389937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and function of ephrin-B1 and its cognate receptor EphB2 in human atherosclerosis: from an aspect of chemotaxis.
    Sakamoto A; Ishibashi-Ueda H; Sugamoto Y; Higashikata T; Miyamoto S; Kawashiri MA; Yagi K; Konno T; Hayashi K; Fujino N; Ino H; Takeda Y; Yamagishi M
    Clin Sci (Lond); 2008 May; 114(10):643-50. PubMed ID: 18092944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma.
    Tachibana M; Tonomoto Y; Hyakudomi R; Hyakudomi M; Hattori S; Ueda S; Kinugasa S; Yoshimura H
    Dig Liver Dis; 2007 Aug; 39(8):725-32. PubMed ID: 17611172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EFNB1 mutation at the ephrin ligand-receptor dimerization interface in a patient with craniofrontonasal syndrome.
    Torii C; Izumi K; Nakajima H; Takahashi T; Kosaki K
    Congenit Anom (Kyoto); 2007 Mar; 47(1):49-52. PubMed ID: 17300690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human osteosarcoma expresses specific ephrin profiles: implications for tumorigenicity and prognosis.
    Varelias A; Koblar SA; Cowled PA; Carter CD; Clayer M
    Cancer; 2002 Aug; 95(4):862-9. PubMed ID: 12209731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulated expression of S100A6 in human gastric cancer.
    Yang YQ; Zhang LJ; Dong H; Jiang CL; Zhu ZG; Wu JX; Wu YL; Han JS; Xiao HS; Gao HJ; Zhang QH
    J Dig Dis; 2007 Nov; 8(4):186-93. PubMed ID: 17970874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of EphB2 and ephrin-B2 at the optic nerve head of DBA/2J glaucomatous mice coincides with axon loss.
    Du J; Tran T; Fu C; Sretavan DW
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5567-81. PubMed ID: 18055806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers.
    Lugli A; Spichtin H; Maurer R; Mirlacher M; Kiefer J; Huusko P; Azorsa D; Terracciano L; Sauter G; Kallioniemi OP; Mousses S; Tornillo L
    Clin Cancer Res; 2005 Sep; 11(18):6450-8. PubMed ID: 16166419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Value of EphB2 Receptor and Cognate Ephrin Ligands in Prognostic and Predictive Assessments of Human Breast Cancer.
    Ebrahim AS; Hailat Z; Bandyopadhyay S; Neill D; Kandouz M
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EphB2 and ephrin-B1 expressed in the adult kidney regulate the cytoarchitecture of medullary tubule cells through Rho family GTPases.
    Ogawa K; Wada H; Okada N; Harada I; Nakajima T; Pasquale EB; Tsuyama S
    J Cell Sci; 2006 Feb; 119(Pt 3):559-70. PubMed ID: 16443753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer--association with tumour cell proliferation.
    Grabsch H; Takeno S; Parsons WJ; Pomjanski N; Boecking A; Gabbert HE; Mueller W
    J Pathol; 2003 May; 200(1):16-22. PubMed ID: 12692836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relations of transforming growth factor-beta1 expression to differentiation and prognosis of advanced gastric cancer].
    Guo RF; Zang SZ; Zhang L; Li WM; Hu FL; Lü YY
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3249-54. PubMed ID: 17313802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of EphB receptors and EphrinB ligands in the developing chick auditory brainstem.
    Cramer KS; Karam SD; Bothwell M; Cerretti DP; Pasquale EB; Rubel EW
    J Comp Neurol; 2002 Oct; 452(1):51-64. PubMed ID: 12205709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of GAGE gene can predict aggressive biologic behavior of intestinal type of stomach cancer.
    Kong U; Koo J; Choi K; Park J; Chang H
    Hepatogastroenterology; 2004; 51(59):1519-23. PubMed ID: 15362791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers.
    Wang JY; Hsieh JS; Chen CC; Tzou WS; Cheng TL; Chen FM; Huang TJ; Huang YS; Huang SY; Yang T; Lin SR
    J Surg Res; 2004 Aug; 120(2):242-8. PubMed ID: 15234219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of c-erb-B2 proteins in tumor and non-tumor parts of gastric adenocarcinoma--emphasis on its relation to H. pylori infection and clinicohistological characteristics.
    Wang YL; Sheu BS; Yang HB; Lin PW; Chang YC
    Hepatogastroenterology; 2002; 49(46):1172-6. PubMed ID: 12143229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between the EPHB2 receptor and EFNB1 ligand drives gastric cancer invasion and metastasis via the Wnt/β-catenin/FAK pathway.
    Hu Y; Xie Q; Zhao J; Yang R; Qin J; Li H; Zhao Y; Du X; Shi C
    Int J Biol Macromol; 2024 Feb; 258(Pt 1):128848. PubMed ID: 38114003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.